Researchers studying tear-lipid fingerprints associated with aqueous-deficient dry eye (ADDE) and Meibomian-gland dysfunction ...

Dave Abroamowitz of Thermo Fisher Cientific concludes his five-part video series with thoughts on how laboratories can address potential biases or errors introduced by artificial intelligence (AI) ...

Research regarding the connection between sodium intake and cadiometabolic risk used ultrahigh performance liquid ...

Artificial intelligence (AI) will of course revolutionize method development, peak detection, and data interpretation as it becomes more widely applied and accepted. We asked Dave Abramowitz of Thermo ...

Australian researchers set out to determine the chemical composition of anabolic–androgenic steroid (AAS) sold there, ...

The September issue of LCGC International delivers new perspectives in oligonucleotide analysis, robust data statistics, and advanced workflows for complex biologics.

Researchers aiming to investigate the value of serum vitamin D3 levels in patients with a history of malignancy and confirmed ...

High-quality, well-labeled data is essential. What steps are being taken—or should be taken—to create standardized, shared chromatographic datasets for AI training? Dave Abramowitz of Thermo Fisher ...

This article explores advanced oligonucleotide analysis techniques, including chromatography methods for therapeutic RNA, ...

In this episode of Analytically Speaking, explore the intersection of forensic science and cannabis research with Brent ...

LCGC International spoke to Dave Abramowitz, unified product management and product ownership team for chromatography and ...

What role will human expertise have when artificial intelligence (AI) becomes more deeply embedded in chromatography workflows? Dave Abramowitz of Thermo Fisher Scientific shares his thoughts.